Twenty-year trends in long-term mortality risk in 17 149 survivors of ischemic stroke less than 55 years of age

Stroke

Volumn 44, Issue 12, 2013, Pages 3338-3343

  Giang, Kok Wai ^a   Björck, Lena ^a   Nielsen, Susanne ^a   Novak, Masuma ^a   Sandström, Tatiana Zverkova ^a   Jern, Christina ^b   Torén, Kjell ^a,c   Rosengren, Annika ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Department of Clinical Neurosciences and Rehabilitation ^*  (Sweden)

^c Division of Occupational and Environmental Medicine   (Sweden)

Author keywords

Age factors; Epidemiology; Ischemic; Mortality; Stroke; Survival; Trends

Indexed keywords

ADULT; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; FEMALE; FOLLOW UP; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; STANDARDIZED MORTALITY RATIO; SURVIVAL TIME; SURVIVOR; TREND STUDY;

AGE FACTORS; EPIDEMIOLOGY; ISCHEMIC; MORTALITY; STROKE; SURVIVAL; TRENDS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BRAIN ISCHEMIA; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REGISTRIES; RISK; SEX DISTRIBUTION; STROKE; SURVIVAL RATE; SURVIVORS;

EID: 84889262119     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.002936     Document Type: Article

References (37)

1. Nichols M, Townsend N, Scarborough P, Luengo-Fernandez R, Leal J, Gray A, et al. European Cardiovascular Disease Statistics. Brussels: European Heart Network, Sophia Antipolis: European Society of Cardiology; 2012.
2. Redon J, Olsen MH, Cooper RS, Zurriaga O, Martinez-Beneito MA, Laurent S, et al. Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure. Eur Heart J. 2011;32:1424-1431.
3. Sivenius J, Tuomilehto J, Immonen-Raiha P, Kaarisalo M, Sarti C, Torppa J, et al. Continuous 15-year decrease in incidence and mortality of stroke in Finland: the FINSTROKE study. Stroke. 2004;35:420-425.
4. Peltonen M, Stegmayr B, Asplund K. Time trends in long-term survival after stroke: the Northern Sweden Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) study, 1985-1994. Stroke. 1998;29:1358-1365.
5. Rosengren A, Giang KW, Lappas G, Jern C, Toren K, Bjorck L. Twentyfour-year trends in the incidence of ischemic stroke in sweden from 1987 to 2010. Stroke. 2013;44:2388-2393.
6. Kissela BM, Khoury JC, Alwell K, Moomaw CJ, Woo D, Adeoye O, et al. Age at stroke: temporal trends in stroke incidence in a large, biracial population. Neurology. 2012;79:1781-1787.
7. Vaartjes I, O'Flaherty M, Capewell S, Kappelle J, Bots M. Remarkable decline in ischemic stroke mortality is not matched by changes in incidence. Stroke. 2013;44:591-597.
8. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and casefatality in the late 20th century. Lancet Neurol. 2003;2:43-53.
9. Chen RL, Balami JS, Esiri MM, Chen LK, Buchan AM. Ischemic stroke in the elderly: an overview of evidence. Nat Rev Neurol. 2010;6:256-265.
10. Nedeltchev K, der Maur TA, Georgiadis D, Arnold M, Caso V, Mattle HP, et al. Ischaemic stroke in young adults: predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry. 2005;76:191-195.
11. Bronnum-Hansen H, Davidsen M, Thorvaldsen P. Long-term survival and causes of death after stroke. Stroke. 2001;32:2131-2136.
12. Rutten-Jacobs LC, Arntz RM, Maaijwee NA, Schoonderwaldt HC, Dorresteijn LD, van Dijk EJ, et al. Long-term mortality after stroke among adults aged 18 to 50 years. JAMA. 2013;309:1136-1144.
13. Varona JF, Bermejo F, Guerra JM, Molina JA. Long-term prognosis of ischemic stroke in young adults. Study of 272 cases. J Neurol. 2004;251:1507-1514.
14. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
15. Ruiz-Sandoval JL, Cantu C, Barinagarrementeria F. Intracerebral hemorrhage in young people: analysis of risk factors, location, causes, and prognosis. Stroke. 1999;30:537-541.
16. Putaala J, Curtze S, Hiltunen S, Tolppanen H, Kaste M, Tatlisumak T. Causes of death and predictors of 5-year mortality in young adults after first-ever ischemic stroke: the Helsinki Young Stroke Registry. Stroke. 2009;40:2698-2703.
17. Naess H, Nyland HI, Thomassen L, Aarseth J, Myhr KM. Long-term outcome of cerebral infarction in young adults. Acta Neurol Scand. 2004;110:107-112.
18. Eriksson M, Holmgren L, Janlert U, Jansson JH, Lundblad D, Stegmayr B, et al. Large improvements in major cardiovascular risk factors in the population of northern Sweden: the MONICA study 1986-2009. J Intern Med. 2011;269:219-231.
19. Johansson S, Wilhelmsen L, Welin C, Eriksson H, Welin L, Rosengren A. Obesity, smoking and secular trends in cardiovascular risk factors in middle-aged women: data from population studies in Goteborg from 1980 to 2003. J Intern Med. 2010;268:594-603.
20. Ng N, Carlberg B, Weinehall L, Norberg M. Trends of blood pressure levels and management in Vasterbotten County, Sweden, during 1990-2010. Glob Health Action. 2012;5:18195.
21. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376:112-123.
22. Danielsson M, Gilliam H, Hemström Ö. Tobaksvanor och tobaksrelaterade besvär. Folkhälsorapporten 2009. Stockholm: Socialstyrelsen; 2009:292-310.
23. Eliasson M, Talback M, Rosen M. Improved survival in both men and women with diabetes between 1980 and 2004-a cohort study in Sweden. Cardiovasc Diabetol. 2008;7:32.
24. Eliasson M, Janlert U, Jansson JH, Stegmayr B. Time trends in population cholesterol levels 1986-2004: influence of lipid-lowering drugs, obesity, smoking and educational level. The northern Sweden MONICA study. J Intern Med. 2006;260:551-559.
25. Bjorck L, Rosengren A, Bennett K, Lappas G, Capewell S. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J. 2009;30:1046-1056.
26. Glader EL, Stegmayr B, Johansson L, Hulter-Asberg K, Wester PO. Differences in long-term outcome between patients treated in stroke units and in general wards: a 2-year follow-up of stroke patients in sweden. Stroke. 2001;32:2124-2130.
27. Terent A, Asplund K, Farahmand B, Henriksson KM, Norrving B, Stegmayr B, et al. Stroke unit care revisited: who benefits the most? A cohort study of 105,043 patients in Riks-Stroke, the Swedish Stroke Register. J Neurol Neurosurg Psychiatry. 2009;80:88-887.
28. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke. Stroke. 2006;3:577-617.
29. Glader EL, Sjolander M, Eriksson M, Lundberg M. Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke. Stroke. 2010;41:397-401.
30. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267-1278.
31. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-153.
32. Pedersen T, Kjekshus, J, Berg, K, Haghfelt, T. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
33. Collins R, Armitage J, Parish S, Sleigh P, Peto R. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003;361:2005-2016.
34. Freemantle N, Cleland J, Young P, Mason J, Harrison J. beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 1999;318:1730-1737.
35. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
36. Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Diaz R, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet. 2011;378:1231-1243.
37. Appelros P, Terent A. Validation of the Swedish inpatient and causeof-death registers in the context of stroke. Acta Neurol Scand. 2011;123:289-293.